Small biotechs shoulder the burdens of an uncertain biopharma sector
Funding troubles and innovation responsibilities are falling more heavily on emerging biotechs under strain from US developments.
Funding troubles and innovation responsibilities are falling more heavily on emerging biotechs under strain from US developments.
What's Your Reaction?
